Junki Maruyama

This study evaluates a bivalent Lassa virus mRNA vaccine in mice and guinea pigs, showing it provides complete protection against lethal infection, whereas monovalent vaccines do not.

The paper investigates hybridized JUNV-MACV GP1 variants, showing they enable virus entry and are recognized by cross-neutralizing antibodies, suggesting potential for antiviral therapy design.

This study identifies the L protein as a key determinant of pathogenicity in Lassa virus LF2384 compared to LF2350 in guinea pigs through immunological gene profiling and reverse genetics.

This study examines the long-term effects of SARS-CoV-2 on the olfactory system in Syrian golden hamsters, revealing persistent neuronal and glial changes.